Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 3 of 11 pages < 1 2 3 4 5 > Last ›
HSL3611
Smith EL.
Drug promotion in the Third World.
Lancet 1988 Jul 23; 2:(8604):224
HSL3608
Seibel J, Levitz SM.
Minorities in the Journal's advertisements.
N Engl J Med 1988 Jul 7; 319:(1):57-8
HSL9558
Weber LJ.
Getting ready for the Medicare drug benefit
Consultant Pharmacist 1988 Jul-Aug; 3:303, 306
HSL20491
McIntosh P
Drug companies feel a watchdog's bite
The Age 1988 Jun 48
HSL3639
Re: the promotion of cefuroxime, cyanocobalamin, cephalexin, ranitidine and guaiphenesin
1988 Jun;
HSL9563
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association
Journal Michigan Pharmacist 1988 Jun; 26:34-35
HSL9575
Innovation in drug sampling now being launched
Hospital Pharmacy 1988 Jun; 23:576
HSL2002
World Health Organization
Ethical Criteria for Medicinal Drug Promotion
1988 May 13
http://web.archive.org/web/20050830010930/http://www.who.int/medicines/library/dap/ethical-criteria/ethicalen.shtml
HSL3635
Fisher DA.
The golden age of CME is yet to come [2nd of 3 letters]
JAMA 1988 May 6; 259:(17):2545
HSL3636
Madigan HS.
The golden age of CME is yet to come [1st of 3 letters]
JAMA 1988 May 6; 259:(17):2544-2545
HSL3637
Manning PR, Petit DW.
The golden age of CME is yet to come [reply]
JAMA 1988 May 6; 259:(17):2545-2546
HSL3638
Scarpinato L, Govaker D.
The golden age of CME is yet to come [3rd of 3 letters]
JAMA 1988 May 6; 259:(17):2545
HSL20486
Norington B
Why a company offered doctors fun and Games
The Sydney Morning Herald 1988 May 4
HSL20487
Swan N
Drug sales talk could be misleading, experts say
The Sydney Morning Herald 1988 May 46
HSL9562
Gebhart F.
California limits manufacturer liability in DES suit
Drug Topics 1988 May 2; 132:44
HSL3620
Wein PJ, Hoffmann RP.
What really sells a drug today?
Hosp Pharm 1988 May; 23:(5):478-9
HSL3630
Healthcare communications and pharmaceutical promotion
Health Horizons 1988 May; (4):16-17
HSL3631
The international industry discusses marketing standards
Health Horizons 1988 May; (4):18-19
HSL3632
Re: the promotion of high dose oestradiol and progesterone and high dose oestradiol and testosterone
1988 May;
HSL3633
Kaplar RT.
It's time to remove the brief summary from DTC print ads
Medical Marketing & Media 1988 May; 33:(5):44-46, 48
HSL3634
Williams JD.
Editorial
Health Horizons 1988 May; (4):2
HSL9557
Laitin JA.
Sampling confusion: Prescription Drug Marketing Act of 1988
Pharmaceutical Executive 1988 May; 8:60, 62, 64
HSL9574
Socha M.
Do you really know what you're dispensing?
Canadian Pharmaceutical Journal 1988 May; 121:308-310
HSL9576
McCormick EM.
How drug sampling has become involved in drug diversion
Pharmacy Times 1988 May; 54:134-137
HSL9579
Mossinghoff GJ.
Opposition to therapeutic interchange.
Am J Hosp Pharm 1988 May; 45:(5):1065
HSL3627
Anstice DW.
Diflunisal advertising [2nd of 2 replies]
Medical Journal of Australia 1988 Apr 18; 148:418, 420
HSL3556
Krass M.
New code for drug makers tightens rules on drug samples, research.
CMAJ 1988 Apr 1; 138:(7):646
HSL3626
Good promotional practice (GPP)
Health Action International 1988 Apr;
www.haiweb.org
HSL9573
Simonsen LL.
Top 200 drugs of 1987: new prescription volume increases 4.2% moving total Rxs up 1.4%
Pharmacy Times 1988 Apr; 54:38-46
HSL9578
Illinois Supreme Court rules on third party liability for hospitals
American Journal of Hospital Pharmacy 1988 Apr; 45:741-742
HSL9580
Fay JT.
Seeking self-reliance
Wholesale Drugs Magazine 1988 Apr-May; 40:14
HSL20216
Baron J, Hershey JC.
Outcome bias in decision evaluation.
J Pers Soc Psychol 1988 Apr; 54:(4):569-79
http://www.ncbi.nlm.nih.gov/pubmed/3367280
HSL3567
Miles S.
Searle's "Patient Promise".
N Engl J Med 1988 Mar 24; 318:(12):790
HSL9568
Roberts K, Sharp JR.
Original packs-what do patients think?
Pharmaceutical Journal 1988 Mar 19; 240:382-384
HSL2094
Taylor SE, Brown JD.
Illusion and well-being: a social psychological perspective on mental health.
Psychol Bull 1988 Mar; 103:(2):193-210
http://content.apa.org/journals/bul/103/2/193
HSL9554
Top 50 generics of 1987
American Druggist 1988 Mar; 197:83-84, 87
HSL9581
Segal R, Grines LL.
Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry.
Drug Intell Clin Pharm 1988 Mar; 22:(3):241-6
HSL9583
Penna PM.
Marketing formulary drug products: pharmacy-industry cooperation
American Journal of Hospital Pharmacy 1988 Mar; 45:518
HSL9585
Brandon W.
Let the manufacturer explain increases.
Am Pharm 1988 Mar; NS28:(3):6
HSL3539
Cohen EP.
Direct-to-the-public advertisement of prescription drugs.
N Engl J Med 1988 Feb 11; 318:(6):373-6
HSL3553
[No authors listed] Related Articles, Links Guidelines on postmarketing surveillance.
Joint committee of ABPI, BMA, CSM, and RCGP.
Br Med J (Clin Res Ed) 1988 Feb 6; 296:(6619):399-400
HSL3623
MaLAM letter follow up—Janssen
1988 Feb;
HSL3624
Re: the promotion of penicillin/streptomycin combination
1988 Feb;
HSL9571
Schwartz H.
Fee for service will never be outdated
Pharmaceutical Executive 1988 Feb; 8:12, 14
HSL9572
Detels P.
Adding OTCs to ethicals: double markets or double trouble?
Pharmaceutical Executive 1988 Feb; 8:43-44, 46
HSL3569
Murdoch JC.
An open assessment of tenoxicam in the treatment of acute gout in general practice.
N Z Med J 1988 Jan 27; 101:(838):21
HSL3621
Wells F.
Management of clinical trials.
Lancet 1988 Jan 16; 1:(8577):124
HSL3606
Rubin JN, Widerhorn J, Elkayam U.
Nitroglycerin tolerance.
N Engl J Med 1988 Jan 14; 318:(2):120
HSL3619
Weary PE.
Free drug samples: Use and abuse.
Arch Dermatol 1988 Jan 12; 4:(1):125-7
HSL1876
[No authors listed]
"A matter of influence": graduate medical education and commercial sponsorship.
N Engl J Med. 1988 Jan 7;318(1):52-4 1988 Jan 7; 318:(1):52-4
HSL3547
[No authors listed] Related Articles, Links Improving medical education in therapeutics.
Health and Public Policy Committee, American College of Physicians.
Ann Intern Med 1988 Jan; 108:(1):145-7
HSL3566
McLeod DC.
Pharmaceutical marketing--rewriting the textbook.
Drug Intell Clin Pharm 1988 Jan; 22:(1):62
HSL3622
Re: the promotion of vitamins A & E
1988 Jan;
HSL9551
Harvey KJ.
Influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988 Jan; 18:25-27
HSL1877
Bowman MA, Pearle DL.
Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
J Contin Educ Health Prof 1988; 8:(1):13-20
HSL3528
Breaches of Code of Pharmaceutical Marketing Practice
Lancet 1988; 1:1179
HSL3529
International drug marketing code
Lancet 1988; 1:988
HSL3530
International medical advertising
Lancet 1988; 1:350
HSL3531
New marketing promotion guidelines for drug firms
Ontario Medical Review 1988; 55:(3):57-58
HSL3532
Post-marketing surveillance by drug manufacturers
Lancet 1988; 2:977
HSL3533
Promoting health or promoting drugs? A HAI presentation on rational drug use
Health Action International 1988;
www.haiweb.org
HSL3534
An unscrupulous advertisement
Lancet 1988; 1:1098
HSL3535
Baldini R.
Nitroglycerin tolerance
New England Journal of Medicine 1988; 318:120
HSL3536
Bone S, Wild R.
A glimpse before publication
Lancet 1988; 1:1054
HSL3537
Boyle JA.
Searle’s “patient promise”
New England Journal of Medicine 1988; 318:790
HSL3538
Cohen EP.
Advertising of prescription drugs
New England Journal of Medicine 1988; 319:314-315
HSL3540
Collier J, Herxheimer A.
Medicines Act passes crucial test
Lancet 1988; 1:1349
HSL3541
Ferguson A.
Commercial pharmaceutical medicine and medicalization: a case study from El Salvador
1988;
HSL3542
Frishman W.
Pharmaceutical company-sponsored symposia and medical ethics
American Journal of Medicine 1988; 85:597
HSL3543
Goldfinger S.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:53
HSL3544
Harvey K.
The impact of the WHO ethical criteria for medicinal drug promotion: a study by Health Action International (HAI)
1988; 4
www.haiweb.org
HSL3545
Harvey K.
The influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988; 18:(3):25-28
HSL3546
Hawkins JW, Aber CS.
The content of advertisements in medical journals: distorting the image of women.
Women Health 1988; 14:(2):43-59
HSL3548
Heilman SR.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:53
HSL3549
Hemminki E.
Commercial information on drugs: confusing the physician?
Journal of Drug Issues 1988; 18:245-257
HSL3550
Holloway WJ.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:New England Journal of Medicin
HSL3551
Hopley PJ, Rich AJ.
Pharmaceutical company representatives - an activity analysis
Pharmaceutical Journal 1988; 241:R21-22
HSL3552
Hurwitz MA, Caves RE.
Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals
Journal of Law and Economics 1988; 31:299-320
HSL3557
Kunin CM.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:53
HSL3559
Lefkowitz D.
Rap sheet on reps: the doctor will see you now
Pharmaceutical Executive 1988; 8:(6):
HSL3561
Lexchin J.
Introducing a new drug: an objection
Canadian Family Physician 1988; 34:1009-1010
HSL3562
Lexchin J.
Pharmaceutical promotion in New Zealand.
Community Health Stud 1988; 12:(3):264-72
HSL3563
Marsh AA.
Junk mail
Canadian Medical Association Journal 1988; 138:791
HSL3564
Masson A, Rubin PH.
Advertising of prescription drugs
New England Journal of Medicine 1988; 319:314
HSL3565
McGregor M.
Pharmaceutical “generosity” and the medical profession
Annals of the Royal College of Physicians and Surgeons of Canada 1988; 21:289
HSL3568
Mossinghoff GJ.
Costs of drug advertising
New England Journal of Medicine 1988; 319:798
HSL3572
Osiobe SA.
Physicians’ and pharmacists’ drug information sources in Nigeria
Drug Information Journal 1988; 22:553-563
HSL3573
Palmer WH, Ross DL.
Introducing a new drug: a response
Canadian Family Physician 1988; 34:1010
HSL3574
Pearse WH.
Advertising of prescription drugs
New England Journal of Medicine 1988; 319:314
HSL3575
Peay MY, Peay ER.
The role of commercial sources in the adoption of a new drug.
Soc Sci Med 1988; 26:(12):1183-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2905075&query_hl=47
HSL3576
Pitt L, Nel D.
Pharmaceutical promotion tools—their relative importance
European Journal of Marketing 1988; 22:7-14
HSL3577
Pleil AM, Pathak DS.
Commercial drug compendium information: a First World/Third World comparison.
Int J Health Serv 1988; 18:(4):587-602
HSL3602
Relman AS.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:53-54
HSL3603
Relman AS.
Minorities in the Journal’s advertisements
New England Journal of Medicine 1988; 319:58
HSL3604
Roizen R.
Why I oppose drug company payment of physician/investigators on a per patient/subject basis
IRB: a review of human subjects research 1988; 10:(1):9-10
HSL3605
Rosenblatt RA.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:52-53
HSL3607
Schiedermayer , McKinney WP.
The Feldene connection: drug dealing in the doctors’ parking lot?
New England Journal of Medicine 1988; 319:1291-1292
HSL3609
Semple PF.
Disguised promotion of drugs
Lancet 1988; 1:768
HSL3612
Sterky G, Tomson G, Sachs L, Henningsson B, Bergman U.
Medicines and society: a challenge in health development
1988;
HSL3614
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988;
Page 3 of 11 pages < 1 2 3 4 5 > Last ›
